Awaiting product image

Article: Long-term benefit of acalabrutinib in first-line CLL: 6-year update from ELEVATE-TN

€3.03

SKU: product-article-44226 Category:

Description

Long-term benefit of acalabrutinib in first-line CLL: 6-year update from ELEVATE-TN

Reviews

There are no reviews yet.

Be the first to review “Article: Long-term benefit of acalabrutinib in first-line CLL: 6-year update from ELEVATE-TN”

Related products